Sibelco’s HPQ Recovery Lags Tariff Headwinds—Is the Stock Pricing in a Broken Business?

Sibelco's 2025 financial print was a study in resilience. The company delivered sales of EUR 2,237.23 million and net income of EUR 146.31 million for the full year. On the surface, that's a modest gain-revenue up just 0.6% from the prior year. Yet the market's muted reaction suggests these headline numbers were already fully priced in. The real story, and the source of the expectation gap, lies beneath the top line in the persistent pressure on margins and cash flow.

The resilience came from diversification. While one key business struggled, others held the line. Specifically, Europe and our US glass recycling business offset a subdued HPQ performance. This portfolio balance is the core of Sibelco's operating model, and it worked as intended in 2025. The company maintained its EBITDA broadly in line with the previous year, a critical achievement in a tough environment.

The drag, however, was clear and persistent. The high purity quartz (HPQ) business remained subdued, a direct consequence of two headwinds. First, it was still recovering from Hurricane Helene. Second, ongoing US–China tariff negotiations impacted our HPQ business as it continued its recovery. These factors disrupted exports and kept that segment from contributing more significantly to growth. For investors, this wasn't a surprise-it was the known challenge. The whisper number likely already baked in a flat or slightly down HPQ story. The disappointment, if any, came from the lack of a stronger offset from other segments and the continued margin pressure that kept EBITDA flat despite the revenue tick higher.

In essence, Sibelco delivered the expected print. The market had already priced in the HPQ drag and the need for diversification to hold revenue steady. The expectation gap wasn't in the headline numbers; it was in the quality of the earnings and the forward visibility on when the HPQ recovery would truly accelerate.

The Expectation Gap: Stock Reaction and Guidance Reset

The market's verdict on Sibelco's 2025 print was a clear "sell the news." Despite the headline resilience, the stock has been under pressure, with shares down 12.7% year to date and 5.7% over the past year. This weak performance highlights a disconnect: the company delivered the expected result, but the quality of that result and the path to get there failed to meet the market's forward-looking expectations.

The rocky path to maintaining EBITDA is the core of that disconnect. While full-year EBITDA held steady, the journey was volatile. The company faced a 16% decline in H1 EBITDA, driven by a combination of factors. The primary culprit was the subdued HPQ performance, which continued to struggle with recovery from Hurricane Helene and tariff headwinds. Compounding that was a weaker US dollar, which hurt the value of dollar-denominated earnings. This sharp first-half drop was a major red flag that the market had not fully priced in, creating an expectation gap that the stock has yet to close.

Now, the focus has shifted decisively to the guidance reset and its cash flow impact. The lower H1 EBITDA and a significant increase in working capital are the key inputs driving the current market anxiety. These factors directly pressure free cash flow, which is the lifeblood of the valuation models that are now signaling extreme overvaluation. The DCF model, for instance, projects a steep decline in free cash flow from €14.72 million last twelve months to €11.34 million in 2026. When the market sees a guidance reset that implies this cash flow trajectory, it recalibrates its risk assessment and discount rate, leading to the sustained sell-off.

The bottom line is that Sibelco's 2025 results confirmed the known challenges but also revealed a more fragile path to earnings stability than investors had hoped. The stock's weak performance reflects a reset in expectations, moving away from the "resilience" narrative toward a more cautious view on cash generation and the timing of a full HPQ recovery.

Valuation Disconnect: DCF vs. P/E and the "Buy the Rumor" Trap

The market's verdict on Sibelco's valuation is stark: there is no clear discount. The stock scores a zero out of six on standard undervaluation tests, indicating that none of the common metrics signal a bargain. This absence of a margin of safety is a key expectation gap in itself. For a stock trading at €4,760.00, the valuation is not cheap-it is priced for perfection, and the recent sell-off suggests the market is recalibrating away from that fantasy.

The most glaring disconnect comes from the Discounted Cash Flow model. This forward-looking approach projects a steep decline in free cash flow, from €14.72 million last twelve months to just €11.34 million in 2026. When these deteriorating cash flows are discounted back to today, the model implies an intrinsic value of €380.59 per share. That figure is a massive overvaluation gap against the current price. In other words, the market is pricing in a recovery and growth trajectory that the DCF model, based on current guidance and trends, cannot support.

This sets up a classic "buy the rumor, sell the news" dynamic. The stock's weak performance reflects a market that has already priced in the known challenges-HPQ's recovery from Hurricane Helene and tariff headwinds. Now, the focus is on the next catalyst: the full-year 2026 guidance. This report will be the definitive test. It will signal whether the HPQ recovery is accelerating as hoped, or if the tariff pressures are worsening and further eroding the cash flow trajectory the DCF model already sees as bleak. Any guidance that confirms the projected cash flow decline would validate the DCF's pessimistic view and likely keep the stock under pressure. Conversely, a strong beat and raise could temporarily reprice the stock, but it would need to be substantial to close the expectation gap created by the current valuation and the rocky path to stability.

Catalysts and Risks: The Path to a New Baseline

The path forward for Sibelco hinges on execution and a shift in the market's narrative. The current valuation, which prices in perfection, leaves no room for error. The company's ability to justify its price will be determined by two critical factors: the tangible progress on its new strategy and the market's willingness to believe in a turnaround.

First, the new 'Build 2030' strategy is the definitive catalyst. As CEO Hilmar Rode stated, the plan is to further strengthen our core business by reinforcing Sibelco's global leadership in industrial silica, HPQ and recycled glass. For the stock to re-rate, investors need to see this strategy move from announcement to measurable results. The focus will be on whether the company can accelerate the HPQ recovery from Hurricane Helene and navigate tariff pressures to turn that segment into a growth engine, not just a stable contributor. Execution here is non-negotiable; it will determine if the diversification story can evolve into a growth story.

Second, the key risk is that the stock's poor performance reflects a broader, more permanent reassessment. The market has already priced in the known challenges of 2025. The continued sell-off suggests investors are now questioning the company's long-term growth trajectory and profitability. This makes it difficult to 'buy the rumor' of a turnaround. The valuation disconnect, with the stock scoring zero on undervaluation tests, means any future disappointment will be punished severely. The market is not waiting for a perfect recovery; it is demanding proof of a new, more profitable baseline.

A key event on the horizon is the Ordinary General Assembly on 23 April 2025. While primarily a governance meeting, it serves as a formal platform for shareholder updates. Given the context of the recent sell-off and the strategic pivot, this gathering could be a venue for potential strategic announcements or clarifications. It will be a moment for management to re-engage with investors and reinforce the Build 2030 roadmap, aiming to close the expectation gap that has persisted since the 2025 results.

The bottom line is that Sibelco is at a crossroads. The company has delivered the expected resilience, but the market now demands a new baseline of growth and cash flow. The path to justifying the current price runs through flawless execution of Build 2030 and a successful reset of the growth narrative. Any stumble will confirm the market's cautious view, while a credible acceleration could spark a re-rating. For now, the stock's weak performance signals that the market is waiting for proof.